Gotham Asset Management’s ADMA Biologics ADMA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.98M | Sell |
108,993
-55,254
| -34% | -$1.01M | 0.01% | 932 |
|
|
2025
Q1 | $3.26M | Sell |
164,247
-2,447
| -1% | -$48.5K | 0.03% | 647 |
|
|
2024
Q4 | $2.86M | Buy |
166,694
+2,129
| +1% | +$36.5K | 0.03% | 639 |
|
|
2024
Q3 | $3.29M | Buy |
164,565
+86,417
| +111% | +$1.73M | 0.03% | 597 |
|
|
2024
Q2 | $874K | Sell |
78,148
-17,332
| -18% | -$194K | 0.01% | 927 |
|
|
2024
Q1 | $630K | Buy |
95,480
+25,891
| +37% | +$171K | 0.01% | 973 |
|
|
2023
Q4 | $315K | Sell |
69,589
-6,030
| -8% | -$27.3K | 0.01% | 1126 |
|
|
2023
Q3 | $271K | Buy |
75,619
+14,564
| +24% | +$52.1K | 0.01% | 1141 |
|
|
2023
Q2 | $225K | Buy |
61,055
+29,532
| +94% | +$109K | ﹤0.01% | 1201 |
|
|
2023
Q1 | $104K | Sell |
31,523
-10,987
| -26% | -$36.4K | ﹤0.01% | 1287 |
|
|
2022
Q4 | $165K | Buy |
+42,510
| New | +$165K | ﹤0.01% | 1146 |
|